Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.

Li BK, Vasiljevic A, Dufour C, Yao F, Ho BLB, Lu M, Hwang EI, Gururangan S, Hansford JR, Fouladi M, Nobusawa S, Laquerriere A, Delisle MB, Fangusaro J, Forest F, Toledano H, Solano-Paez P, Leary S, Birks D, Hoffman LM, Szathmari A, Faure-Conter C, Fan X, Catchpoole D, Zhou L, Schultz KAP, Ichimura K, Gauchotte G, Jabado N, Jones C, Loussouarn D, Mokhtari K, Rousseau A, Ziegler DS, Tanaka S, Pomeroy SL, Gajjar A, Ramaswamy V, Hawkins C, Grundy RG, Hill DA, Bouffet E, Huang A, Jouvet A.

Acta Neuropathol. 2019 Dec 9. doi: 10.1007/s00401-019-02111-y. [Epub ahead of print]

PMID:
31820118
2.

Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.

Lake JA, Donson AM, Prince E, Davies KD, Nellan A, Green AL, Mulcahy Levy J, Dorris K, Vibhakar R, Hankinson TC, Foreman NK, Ewalt MD, Kleinschmidt-DeMasters BK, Hoffman LM, Gilani A.

Pediatr Blood Cancer. 2020 Jan;67(1):e28028. doi: 10.1002/pbc.28028. Epub 2019 Oct 8.

PMID:
31595628
3.

Targeting IL-6 Is a Potential Treatment for Primary Cystic Craniopharyngioma.

Grob S, Mirsky DM, Donson AM, Dahl N, Foreman NK, Hoffman LM, Hankinson TC, Mulcahy Levy JM.

Front Oncol. 2019 Aug 21;9:791. doi: 10.3389/fonc.2019.00791. eCollection 2019.

4.

A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor.

Sin-Chan P, Mumal I, Suwal T, Ho B, Fan X, Singh I, Du Y, Lu M, Patel N, Torchia J, Popovski D, Fouladi M, Guilhamon P, Hansford JR, Leary S, Hoffman LM, Mulcahy Levy JM, Lassaletta A, Solano-Paez P, Rivas E, Reddy A, Gillespie GY, Gupta N, Van Meter TE, Nakamura H, Wong TT, Ra YS, Kim SK, Massimi L, Grundy RG, Fangusaro J, Johnston D, Chan J, Lafay-Cousin L, Hwang EI, Wang Y, Catchpoole D, Michaud J, Ellezam B, Ramanujachar R, Lindsay H, Taylor MD, Hawkins CE, Bouffet E, Jabado N, Singh SK, Kleinman CL, Barsyte-Lovejoy D, Li XN, Dirks PB, Lin CY, Mack SC, Rich JN, Huang A.

Cancer Cell. 2019 Jul 8;36(1):51-67.e7. doi: 10.1016/j.ccell.2019.06.002.

5.

Treatment of Occipital Neuralgia by Thermal Radiofrequency Ablation.

Hoffman LM, Abd-Elsayed A, Burroughs TJ, Sachdeva H.

Ochsner J. 2018 Fall;18(3):209-214. doi: 10.31486/toj.17.0104.

6.

Correction to: A suggestion to introduce the diagnosis of "diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)".

von Bueren AO, Karremann M, Gielen GH, Benesch M, Fouladi M, van Vuurden DG, Veldhuijzen van Zanten SEM, Hoffman LM, Kramm CM.

Acta Neuropathol. 2018 Oct;136(4):661. doi: 10.1007/s00401-018-1896-x.

PMID:
30159736
7.

Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma.

Donson AM, Amani V, Warner EA, Griesinger AM, Witt DA, Levy JMM, Hoffman LM, Hankinson TC, Handler MH, Vibhakar R, Dorris K, Foreman NK.

Mol Cancer Ther. 2018 Sep;17(9):1984-1994. doi: 10.1158/1535-7163.MCT-17-1185. Epub 2018 Jun 20.

8.

A suggestion to introduce the diagnosis of "diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)".

von Bueren AO, Karremann M, Gielen GH, Benesch M, Fouladi M, van Vuurden DG, van Zanten SEMV, Hoffman LM, Kramm CM.

Acta Neuropathol. 2018 Jul;136(1):171-173. doi: 10.1007/s00401-018-1863-6. Epub 2018 May 21. No abstract available. Erratum in: Acta Neuropathol. 2018 Oct;136(4):661.

PMID:
29785560
9.

Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.

Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M, Lane A, Fuller C, Miles L, Hawkins C, Bartels U, Bouffet E, Goldman S, Leary S, Foreman NK, Packer R, Warren KE, Broniscer A, Kieran MW, Minturn J, Comito M, Broxson E, Shih CS, Khatua S, Chintagumpala M, Carret AS, Escorza NY, Hassall T, Ziegler DS, Gottardo N, Dholaria H, Doughman R, Benesch M, Drissi R, Nazarian J, Jabado N, Boddaert N, Varlet P, Giraud G, Castel D, Puget S, Jones C, Hulleman E, Modena P, Giagnacovo M, Antonelli M, Pietsch T, Gielen GH, Jones DTW, Sturm D, Pfister SM, Gerber NU, Grotzer MA, Pfaff E, von Bueren AO, Hargrave D, Solanki GA, Jadrijevic Cvrlje F, Kaspers GJL, Vandertop WP, Grill J, Bailey S, Biassoni V, Massimino M, Calmon R, Sanchez E, Bison B, Warmuth-Metz M, Leach J, Jones B, van Vuurden DG, Kramm CM, Fouladi M.

J Clin Oncol. 2018 Jul 1;36(19):1963-1972. doi: 10.1200/JCO.2017.75.9308. Epub 2018 May 10.

10.

Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.

Witt DA, Donson AM, Amani V, Moreira DC, Sanford B, Hoffman LM, Handler MH, Levy JMM, Jones KL, Nellan A, Foreman NK, Griesinger AM.

Pediatr Blood Cancer. 2018 May;65(5):e26960. doi: 10.1002/pbc.26960. Epub 2018 Jan 19.

11.

Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology.

Linzey JR, Marini BL, Pasternak A, Smith C, Miklja Z, Zhao L, Kumar-Sinha C, Paul A, Harris N, Robertson PL, Hoffman LM, Chinnaiyan A, Mody R, Koschmann C.

J Neurooncol. 2018 Mar;137(1):155-169. doi: 10.1007/s11060-017-2708-1. Epub 2017 Dec 12.

12.

Characterization of 2 Novel Ependymoma Cell Lines With Chromosome 1q Gain Derived From Posterior Fossa Tumors of Childhood.

Amani V, Donson AM, Lummus SC, Prince EW, Griesinger AM, Witt DA, Hankinson TC, Handler MH, Dorris K, Vibhakar R, Foreman NK, Hoffman LM.

J Neuropathol Exp Neurol. 2017 Jul 1;76(7):595-604. doi: 10.1093/jnen/nlx040.

13.

Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.

Marini BL, Benitez LL, Zureick AH, Salloum R, Gauthier AC, Brown J, Wu YM, Robinson DR, Kumar C, Lonigro R, Vats P, Cao X, Kasaian K, Anderson B, Mullan B, Chandler B, Linzey JR, Camelo-Piragua SI, Venneti S, McKeever PE, McFadden KA, Lieberman AP, Brown N, Shao L, Leonard MAS, Junck L, McKean E, Maher CO, Garton HJL, Muraszko KM, Hervey-Jumper S, Mulcahy-Levy JM, Green A, Hoffman LM, Dorris K, Vitanza NA, Wang J, Schwartz J, Lulla R, Smiley NP, Bornhorst M, Haas-Kogan DA, Robertson PL, Chinnaiyan AM, Mody R, Koschmann C.

Transl Res. 2017 Oct;188:27.e1-27.e14. doi: 10.1016/j.trsl.2017.08.001. Epub 2017 Aug 10.

14.

Oral Health Intervention for Low-Income African American Men in Atlanta, Georgia.

Hoffman LM, Rollins L, Henry Akintobi T, Erwin K, Lewis K, Hernandez N, Miller A.

Am J Public Health. 2017 May;107(S1):S104-S110. doi: 10.2105/AJPH.2017.303760.

15.

External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry.

Veldhuijzen van Zanten SEM, Lane A, Heymans MW, Baugh J, Chaney B, Hoffman LM, Doughman R, Jansen MHA, Sanchez E, Vandertop WP, Kaspers GJL, van Vuurden DG, Fouladi M, Jones BV, Leach J.

J Neurooncol. 2017 Aug;134(1):231-240. doi: 10.1007/s11060-017-2514-9. Epub 2017 May 30.

16.

NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymoma.

Griesinger AM, Witt DA, Grob ST, Georgio Westover SR, Donson AM, Sanford B, Mulcahy Levy JM, Wong R, Moreira DC, DeSisto JA, Balakrishnan I, Hoffman LM, Handler MH, Jones KL, Vibhakar R, Venkataraman S, Foreman NK.

Neuro Oncol. 2017 Oct 1;19(10):1350-1360. doi: 10.1093/neuonc/nox061.

17.

ANG1 treatment reduces muscle pathology and prevents a decline in perfusion in DMD mice.

Gutpell KM, Tasevski N, Wong B, Hrinivich WT, Su F, Hadway J, Desjardins L, Lee TY, Hoffman LM.

PLoS One. 2017 Mar 23;12(3):e0174315. doi: 10.1371/journal.pone.0174315. eCollection 2017.

18.

The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease.

Baugh J, Bartels U, Leach J, Jones B, Chaney B, Warren KE, Kirkendall J, Doughman R, Hawkins C, Miles L, Fuller C, Hassall T, Bouffet E, Lane A, Hargrave D, Grill J, Hoffman LM, Jones C, Towbin A, Savage SA, Monje M, Li XN, Ziegler DS, Veldhuijzen van Zanten S, Kramm CM, van Vuurden DG, Fouladi M.

J Neurooncol. 2017 Apr;132(2):323-331. doi: 10.1007/s11060-017-2372-5. Epub 2017 Jan 16.

19.

Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.

Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A, Norman JD, Guilhamon P, Garzia L, Agamez NR, Lu M, Chan TS, Picard D, de Antonellis P, Khuong-Quang DA, Planello AC, Zeller C, Barsyte-Lovejoy D, Lafay-Cousin L, Letourneau L, Bourgey M, Yu M, Gendoo DMA, Dzamba M, Barszczyk M, Medina T, Riemenschneider AN, Morrissy AS, Ra YS, Ramaswamy V, Remke M, Dunham CP, Yip S, Ng HK, Lu JQ, Mehta V, Albrecht S, Pimentel J, Chan JA, Somers GR, Faria CC, Roque L, Fouladi M, Hoffman LM, Moore AS, Wang Y, Choi SA, Hansford JR, Catchpoole D, Birks DK, Foreman NK, Strother D, Klekner A, Bognár L, Garami M, Hauser P, Hortobágyi T, Wilson B, Hukin J, Carret AS, Van Meter TE, Hwang EI, Gajjar A, Chiou SH, Nakamura H, Toledano H, Fried I, Fults D, Wataya T, Fryer C, Eisenstat DD, Scheinemann K, Fleming AJ, Johnston DL, Michaud J, Zelcer S, Hammond R, Afzal S, Ramsay DA, Sirachainan N, Hongeng S, Larbcharoensub N, Grundy RG, Lulla RR, Fangusaro JR, Druker H, Bartels U, Grant R, Malkin D, McGlade CJ, Nicolaides T, Tihan T, Phillips J, Majewski J, Montpetit A, Bourque G, Bader GD, Reddy AT, Gillespie GY, Warmuth-Metz M, Rutkowski S, Tabori U, Lupien M, Brudno M, Schüller U, Pietsch T, Judkins AR, Hawkins CE, Bouffet E, Kim SK, Dirks PB, Taylor MD, Erdreich-Epstein A, Arrowsmith CH, De Carvalho DD, Rutka JT, Jabado N, Huang A.

Cancer Cell. 2016 Dec 12;30(6):891-908. doi: 10.1016/j.ccell.2016.11.003.

20.

Addressing asthma and obesity in children with community health workers: proof-of-concept intervention development.

Martin MA, Rothschild SK, Lynch E, Christoffel KK, Pagán MM, Rodriguez JL, Barnes A, Karavolos K, Diaz A, Hoffman LM, Plata D, Villalpando S.

BMC Pediatr. 2016 Dec 1;16(1):198.

21.

Assessing the Oral Health Needs of African American Men in Low-Income, Urban Communities.

Akintobi TH, Hoffman LM, McAllister C, Goodin L, Hernandez ND, Rollins L, Miller A.

Am J Mens Health. 2018 Mar;12(2):326-337. doi: 10.1177/1557988316639912. Epub 2016 Mar 23.

22.

Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility.

Piccolo SR, Hoffman LM, Conner T, Shrestha G, Cohen AL, Marks JR, Neumayer LA, Agarwal CA, Beckerle MC, Andrulis IL, Spira AE, Moos PJ, Buys SS, Johnson WE, Bild AH.

Mol Syst Biol. 2016 Mar 10;12(3):860. doi: 10.15252/msb.20156506.

23.

Erratum: Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.

Hoffman LM, DeWire M, Ryall S, Buczkowicz P, Leach J, Miles L, Ramani AK, Brudno M, Kumar SS, Drissi R, Dexheimer P, Salloum R, Chow L, Hummel T, Stevenson C, Lu QR, Jones B, Witte D, Aronow B, Hawkins CE, Fouladi M.

Acta Neuropathol Commun. 2016 Feb 9;4:13. doi: 10.1186/s40478-016-0283-x.

24.

Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.

Hoffman LM, DeWire M, Ryall S, Buczkowicz P, Leach J, Miles L, Ramani A, Brudno M, Kumar SS, Drissi R, Dexheimer P, Salloum R, Chow L, Hummel T, Stevenson C, Lu QR, Jones B, Witte D, Aronow B, Hawkins CE, Fouladi M.

Acta Neuropathol Commun. 2016 Jan 4;4:1. doi: 10.1186/s40478-015-0269-0. Erratum in: Acta Neuropathol Commun. 2016;4:13.

25.

VEGF induces stress fiber formation in fibroblasts isolated from dystrophic muscle.

Gutpell KM, Hoffman LM.

J Cell Commun Signal. 2015 Dec;9(4):353-60. doi: 10.1007/s12079-015-0300-z. Epub 2015 Jul 29.

26.

EWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma.

Fadul J, Bell R, Hoffman LM, Beckerle MC, Engel ME, Lessnick SL.

Genes Cancer. 2015 Mar;6(3-4):129-43.

27.

Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma.

Griesinger AM, Josephson RJ, Donson AM, Mulcahy Levy JM, Amani V, Birks DK, Hoffman LM, Furtek SL, Reigan P, Handler MH, Vibhakar R, Foreman NK.

Cancer Immunol Res. 2015 Oct;3(10):1165-74. doi: 10.1158/2326-6066.CIR-15-0061. Epub 2015 May 12.

28.

Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.

Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, Wani K, Tatevossian R, Punchihewa C, Johann P, Reimand J, Warnatz HJ, Ryzhova M, Mack S, Ramaswamy V, Capper D, Schweizer L, Sieber L, Wittmann A, Huang Z, van Sluis P, Volckmann R, Koster J, Versteeg R, Fults D, Toledano H, Avigad S, Hoffman LM, Donson AM, Foreman N, Hewer E, Zitterbart K, Gilbert M, Armstrong TS, Gupta N, Allen JC, Karajannis MA, Zagzag D, Hasselblatt M, Kulozik AE, Witt O, Collins VP, von Hoff K, Rutkowski S, Pietsch T, Bader G, Yaspo ML, von Deimling A, Lichter P, Taylor MD, Gilbertson R, Ellison DW, Aldape K, Korshunov A, Kool M, Pfister SM.

Cancer Cell. 2015 May 11;27(5):728-43. doi: 10.1016/j.ccell.2015.04.002.

29.

Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.

Hoffman LM, Fouladi M, Olson J, Daryani VM, Stewart CF, Wetmore C, Kocak M, Onar-Thomas A, Wagner L, Gururangan S, Packer RJ, Blaney SM, Gajjar A, Kun LE, Boyett JM, Gilbertson RJ.

Childs Nerv Syst. 2015 Aug;31(8):1283-9. doi: 10.1007/s00381-015-2725-3. Epub 2015 May 1.

30.

Towards risk-adapted therapy for rhabdoid tumour subgroups.

Hoffman LM, Fouladi M.

Lancet Oncol. 2015 May;16(5):486-8. doi: 10.1016/S1470-2045(15)70170-1. Epub 2015 Apr 14. No abstract available.

PMID:
25882984
31.

A multidisciplinary approach to the management of anterior mediastinal masses in children.

Acker SN, Linton J, Tan GM, Garrington TP, Bruny J, Hilden JM, Hoffman LM, Partrick DA.

J Pediatr Surg. 2015 May;50(5):875-8. doi: 10.1016/j.jpedsurg.2014.09.054. Epub 2014 Oct 3.

PMID:
25783332
32.

Molecular biology of pediatric brain tumors and impact on novel therapies.

Hoffman LM, Salloum R, Fouladi M.

Curr Neurol Neurosci Rep. 2015 Apr;15(4):10. doi: 10.1007/s11910-015-0532-6. Review.

PMID:
25690927
33.

Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.

Gutpell KM, Hrinivich WT, Hoffman LM.

PLoS One. 2015 Jan 21;10(1):e0117306. doi: 10.1371/journal.pone.0117306. eCollection 2015.

34.

Pediatric low-grade ganglioglioma: epidemiology, treatments, and outcome analysis on 348 children from the surveillance, epidemiology, and end results database.

Dudley RW, Torok MR, Gallegos DR, Mulcahy-Levy JM, Hoffman LM, Liu AK, Handler MH, Hankinson TC.

Neurosurgery. 2015 Mar;76(3):313-9; discussion 319; quiz 319-20. doi: 10.1227/NEU.0000000000000619.

35.

Application of 3-d echocardiography and gated micro-computed tomography to assess cardiomyopathy in a mouse model of duchenne muscular dystrophy.

Bondoc AB, Detombe S, Dunmore-Buyze J, Gutpell KM, Liu L, Kaszuba A, Han S, McGirr R, Hadway J, Drangova M, Hoffman LM.

Ultrasound Med Biol. 2014 Dec;40(12):2857-67. doi: 10.1016/j.ultrasmedbio.2014.07.015. Epub 2014 Oct 11.

PMID:
25308942
36.

Molecular dissection of the mechanism by which EWS/FLI expression compromises actin cytoskeletal integrity and cell adhesion in Ewing sarcoma.

Chaturvedi A, Hoffman LM, Jensen CC, Lin YC, Grossmann AH, Randall RL, Lessnick SL, Welm AL, Beckerle MC.

Mol Biol Cell. 2014 Sep 15;25(18):2695-709. doi: 10.1091/mbc.E14-01-0007. Epub 2014 Jul 23.

37.

Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth.

Sankar S, Theisen ER, Bearss J, Mulvihill T, Hoffman LM, Sorna V, Beckerle MC, Sharma S, Lessnick SL.

Clin Cancer Res. 2014 Sep 1;20(17):4584-97. doi: 10.1158/1078-0432.CCR-14-0072. Epub 2014 Jun 24.

38.

LIM proteins in actin cytoskeleton mechanoresponse.

Smith MA, Hoffman LM, Beckerle MC.

Trends Cell Biol. 2014 Oct;24(10):575-83. doi: 10.1016/j.tcb.2014.04.009. Epub 2014 Jun 2. Review.

39.
40.

Analysis of chondrogenesis using micromass cultures of limb mesenchyme.

Underhill TM, Dranse HJ, Hoffman LM.

Methods Mol Biol. 2014;1130:251-265. doi: 10.1007/978-1-62703-989-5_19.

PMID:
24482179
41.

Characterization of a far-red analog of ghrelin for imaging GHS-R in P19-derived cardiomyocytes.

Douglas GA, McGirr R, Charlton CL, Kagan DB, Hoffman LM, Luyt LG, Dhanvantari S.

Peptides. 2014 Apr;54:81-8. doi: 10.1016/j.peptides.2014.01.011. Epub 2014 Jan 25.

PMID:
24468548
42.

Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma.

Hoffman LM, Donson AM, Nakachi I, Griesinger AM, Birks DK, Amani V, Hemenway MS, Liu AK, Wang M, Hankinson TC, Handler MH, Foreman NK.

Acta Neuropathol. 2014 May;127(5):731-45. doi: 10.1007/s00401-013-1212-8. Epub 2013 Nov 17.

43.

Pulmonary capillaritis in monozygotic twin boys.

Kupfer O, Ridall LA, Hoffman LM, Dishop MK, Soep JB, Wagener JS, Fan LL.

Pediatrics. 2013 Nov;132(5):e1445-8. doi: 10.1542/peds.2013-0154. Epub 2013 Oct 14.

PMID:
24127476
44.

Characterization of distinct immunophenotypes across pediatric brain tumor types.

Griesinger AM, Birks DK, Donson AM, Amani V, Hoffman LM, Waziri A, Wang M, Handler MH, Foreman NK.

J Immunol. 2013 Nov 1;191(9):4880-8. doi: 10.4049/jimmunol.1301966. Epub 2013 Sep 27.

45.

Fractionated stereotactic radiosurgery for recurrent ependymoma in children.

Hoffman LM, Plimpton SR, Foreman NK, Stence NV, Hankinson TC, Handler MH, Hemenway MS, Vibhakar R, Liu AK.

J Neurooncol. 2014 Jan;116(1):107-11.

46.

LIM domains target actin regulators paxillin and zyxin to sites of stress fiber strain.

Smith MA, Blankman E, Deakin NO, Hoffman LM, Jensen CC, Turner CE, Beckerle MC.

PLoS One. 2013 Aug 21;8(8):e69378. doi: 10.1371/journal.pone.0069378. eCollection 2013.

47.

Evidence-based speech-language pathology practices in schools: findings from a national survey.

Hoffman LM, Ireland M, Hall-Mills S, Flynn P.

Lang Speech Hear Serv Sch. 2013 Jul;44(3):266-80. doi: 10.1044/0161-1461(2013/12-0041).

PMID:
23843652
48.

Pulmonary presentation of relapsed acute myeloid leukemia.

Hoffman LM, Gore L, Maloney KW.

J Pediatr Hematol Oncol. 2014 Apr;36(3):228-30. doi: 10.1097/MPH.0b013e31828e5077.

PMID:
23619108
49.

Introduction: why a Sociology of Pandemics?

Dingwall R, Hoffman LM, Staniland K.

Sociol Health Illn. 2013 Feb;35(2):167-73. doi: 10.1111/1467-9566.12019. Epub 2012 Dec 20.

50.

An exploratory study of clinician real-time morpho-syntactic judgements with pre-school children.

Hoffman LM.

Int J Speech Lang Pathol. 2013 Apr;15(2):198-208. doi: 10.3109/17549507.2012.743033. Epub 2012 Dec 17.

PMID:
23244026

Supplemental Content

Loading ...
Support Center